Company intelligence / Profile preview

要智达

Wuhan, Hubei, China

Ownership: Private
Employees: ~300
Development stage: Other

Overview

Yaozhida (Wuhan) Pharmaceutical Co., Ltd. is a pharmaceutical company based in Wuhan, China, specializing in the development, clinical evaluation, and distribution of generic drugs. The company has focused on therapeutic areas such as dermatology and allergy, notably initiating bioequivalence (BE) trials for products like Fluticasone Propionate Cream. In late 2025, Yaozhida (Wuhan) underwent a strategic merger and reorganization, leading to its integration into Hubei Zhihe Pharmaceutical Co., Ltd. Its business operations encompass pharmaceutical wholesale, medical device distribution, and the marketing of various healthcare products across the Chinese market.

Therapeutic areas: DermatologyImmunology
Modalities: Small molecule
Industry: Biotech

Partnerships

Hubei Zhihe PharmaceuticalJiangsu Wanhe PharmaceuticalSuzhou Gaomai Pharmaceutical

Beyond the preview

Go deeper on 要智达.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on 要智达.

Explore the full profile